CBD Global Sciences Inc. and our cannabidiol (“CBD”) brand “Aethics”, are excited to announce it has finalized the development and launch of a line of edible format gummies (the “Gummies” or “Gummy”) providing measurable consumption of convenient bite-sized CBD hemp extract that will be available in both full spectrum and broad spectrum formats. The Gummies will be offered in a variety of flavors and doses between 10-25 milligrams of CBD hemp extract per Gummy.
The market for gummy wellness vitamins is forecasted to rise at a compound annual growth rate of ~6% between 2019-2029 reaching an aggregate value of US ~$5.8 billion in 2029 according to Transparency Market Research . CBD infused gummies are increasingly gaining popularity as more people realize the benefits of CBD.
CBD Global is launching their Gummy line under the Aethics brand and is also providing full service private label of our Gummies to our carefully selected partners. We offer complete start-to-finish product development services with the current capacity to manufacture up to 4,000,000 units per week in the shapes and flavors preferred by our customers.
Brad Wyatt, CEO & President of the Company, states, “We are excited to offer a new line of high-quality products under our own Aethics brand and to our growing list of distribution partners”. Mr. Wyatt also added, “We will continue our efforts to add high quality products to our line-up and to demonstrate our commitment in listening to our customers and partners needs in the ever-changing CBD marketplace”.
